BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26633608)

  • 21. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptability of human papillomavirus vaccine among parents of junior middle school students in Jinan, China.
    Wang W; Ma Y; Wang X; Zou H; Zhao F; Wang S; Zhang S; Zhao Y; Marley G; Ma W
    Vaccine; 2015 May; 33(22):2570-6. PubMed ID: 25887088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why the "no-brainer" HPV vaccine is being ignored.
    Rubin R
    JAMA; 2015 Apr; 313(15):1502-4. PubMed ID: 25898032
    [No Abstract]   [Full Text] [Related]  

  • 24. The last strategy for re-dissemination of HPV vaccination in Japan while still under the suspension of the governmental recommendation.
    Ueda Y; Yagi A; Abe H; Nakagawa S; Minekawa R; Kuroki H; Miwa A; Kimura T
    Sci Rep; 2020 Sep; 10(1):16091. PubMed ID: 32999408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV vaccination in Japan: what is happening in Japan?
    Ikeda S; Ueda Y; Yagi A; Matsuzaki S; Kobayashi E; Kimura T; Miyagi E; Sekine M; Enomoto T; Kudoh K
    Expert Rev Vaccines; 2019 Apr; 18(4):323-325. PubMed ID: 30768373
    [No Abstract]   [Full Text] [Related]  

  • 26. Should HPV vaccination be mandatory?
    De Soto J
    J Fam Pract; 2007 Apr; 56(4):267-8. PubMed ID: 17403324
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acceptability of vaccination against human papillomavirus (HPV) by pediatricians, mothers and young women in Ho Chi Minh City, Vietnam].
    Phan DP; Pham QT; Strobel M; Tran DS; Tran TL; Buisson Y
    Rev Epidemiol Sante Publique; 2012 Dec; 60(6):437-46. PubMed ID: 23137871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
    Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Hseon TE
    Vaccine; 2009 May; 27(22):2989-93. PubMed ID: 19428910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India.
    Madhivanan P; Krupp K; Yashodha MN; Marlow L; Klausner JD; Reingold AL
    Vaccine; 2009 Aug; 27(38):5203-8. PubMed ID: 19596420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus infection among young adolescents in India: impact of vaccination.
    Hussain S; Bharadwaj M; Nasare V; Kumari M; Sharma S; Hedau S; Das BC
    J Med Virol; 2012 Feb; 84(2):298-305. PubMed ID: 22170551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A brief history of economic evaluation for human papillomavirus vaccination policy.
    Beutels P; Jit M
    Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving adolescent health: focus on HPV vaccine acceptance.
    Zimet GD
    J Adolesc Health; 2005 Dec; 37(6 Suppl):S17-23. PubMed ID: 16310137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Second Shot at HPV.
    Price S
    Tex Med; 2017 Apr; 113(4):29-34. PubMed ID: 28402577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
    Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with intention-to-recommend human papillomavirus vaccination among physicians in Mysore, India.
    Krupp K; Marlow LA; Kielmann K; Doddaiah N; Mysore S; Reingold AL; Madhivanan P
    J Adolesc Health; 2010 Apr; 46(4):379-84. PubMed ID: 20307828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus and papillomavirus vaccines: knowledge, attitudes and intentions of general practitioners and practice nurses in Christchurch.
    Henninger J
    J Prim Health Care; 2009 Dec; 1(4):278-85. PubMed ID: 20690336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [How does it go on with the HPV vaccination?].
    Kaulen H
    Dtsch Med Wochenschr; 2007 Jan; 132(4):132. PubMed ID: 17338090
    [No Abstract]   [Full Text] [Related]  

  • 38. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
    Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
    Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Chasm We Must Cross in Japan for Re-promotion of the HPV Vaccine.
    Ueda Y; Katayama K; Yagi A; Kimura T
    Cancer Prev Res (Phila); 2021 Jul; 14(7):683-686. PubMed ID: 34272250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010.
    Bednarczyk RA; Birkhead GS; Morse DL; Doleyres H; McNutt LA
    Vaccine; 2011 Apr; 29(17):3138-43. PubMed ID: 21376797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.